RT Journal Article
SR Electronic
T1 Clinical characterization of respiratory droplet production during common airway procedures using high-speed imaging
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.01.20144386
DO 10.1101/2020.07.01.20144386
A1 SK Mueller
A1 R Veltrup
A1 B Jakubaß
A1 JS Kempfle
A1 S Kniesburges
A1 MJ Huebner
A1 H Iro
A1 M Döllinger
YR 2020
UL http://medrxiv.org/content/early/2020/07/02/2020.07.01.20144386.abstract
AB Background During the COVID-19 pandemic, a significant number of healthcare workers have been infected with SARS-CoV-2. However, there remains little knowledge regarding droplet dissemination during airway management procedures in real life settings.Methods 12 different airway management procedures were investigated during routine clinical care. A high-speed video camera (1000 frames/second) was for imaging. Quantitative droplet characteristics as size, distance traveled, and velocity were computed.Results Droplets were detected in 8/12 procedures. The droplet trajectories could be divided into two distinctive patterns (type 1/2). Type 1 represented a ballistic trajectory with higher speed droplets whereas type 2 represented a random trajectory of slower particles that persisted longer in air. Speaking and coughing lead to a larger amount of droplets than non-invasive ventilation therapy. The use of tracheal cannula filters reduced the amount of droplets.Conclusions Respiratory droplet patterns generated during airway management procedures follow two distinctive trajectories based on the influence of aerodynamic forces. Speaking and coughing produce more droplets than non-invasive ventilation therapy confirming these behaviors as exposure risks. Even large droplets may exhibit patterns resembling the fluid dynamics smaller airborne aerosols that follow the airflow convectively and may place the healthcare provider at risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sector.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All experimental protocols as well as the study design were approved by the ethics committee of the Friedrich-Alexander-University Erlangen-Nuernberg (No 167_20B).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData openly available in a public repository that issues datasets with DOIARDSacute respiratory distress syndromeCOVID-19coronavirus disease 2019CPAPcontinuous positive airway pressureFFPfiltering face pieceFPSframes per secondLEDlight-emitting diodeMMADmass median aerodynamic diameterPEEPpositive endexpiratory pressurePPEpersonal protective equipmentΔp supportpressure support ventilationSARS-CoV-2severe acute respiratory syndrome coronavirus 2WHOWorld Health Organization